Sort by
Refine Your Search
-
Category
-
Field
-
approaches to complex chronic diseases. It fits fully within the priorities of the Inserm Strategic Plan, particularly the axis dedicated to cardiovascular and brain health and integrative approaches
-
collaborations, and promoting cutting-edge technological innovation to strengthen the French research community. By implementing this strategy, Inserm seeks to support the sustained development and significantly
-
of disabilities and the reduction of costs related to complex bone reconstructions. The recruitment of a CPJ for this project is fully aligned with Inserm's 2020-2025 Strategic Plan because it reinforces
-
INSERM’s strategic plan by establishing a continuum between disruptive fundamental research and the understanding of mechanisms involved in human diseases, leveraging the hospital-university environment
-
its potential impact on subsequent child development, with the goal of addressing a significant public health challenge. This initiative is part of the Health Innovation 2030 Plan and is based
-
Is the Job related to staff position within a Research Infrastructure? No Offer Description 2-YEAR POSTDOCTORAL POSITION AVAILABLE AT NEUROSPIN/INM (PARIS, FRANCE) https://computationalbrainteam.com/en
-
challenges. Partners include universities, hospitals, and international research organizations. One of Inserm's priorities in its 2025 strategic plan (priority 1, objective 2) is to promote disruptive research
-
that is part of the dynamic Saclay scientific hub, combining high-level research, teaching, and innovation at the cutting edge of science and technology. The research conducted covers all modern
-
challenges. Partners include universities, hospitals, and international research organizations. In its national strategic plan, Inserm has identified four key priorities: (i) strengthening the continuum
-
) is in line of the partners’ strategic plan manifested by the creation of the Paris Biofoundry as SU (with CNRS, Inserm among the partners), and by the recruitment of the Inserm U1338 team to join the